ArticleAnnals of surgical oncology2026
Timing and Frequency of Surveillance After Resection of Extremity and Trunk Soft Tissue Sarcoma: Identifying Opportunities for Improvement.
Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Optimising Clinical Outcomes Following R1 Resection in Soft Tissue Sarcoma: An Evidence-Based Approach.Current treatment options in oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
introductionSurveillance practices after resection of extremity and truncal soft-tissue sarcoma (ETSTS) vary, with guidelines recommending physical exam and imaging every 3-6 months. Local and distant recurrence risks differ based on clinicopathological features including tumor grade and histopathologic subtype. The aim of this study was to evaluate surveillance patterns after ETSTS resection at our high-volume sarcoma referral center and determine if opportunities exist to de-escalate intensity of surveillance in appropriate patients.
methodsA retrospective review of patients with primary ETSTS who underwent resection and surveillance at our institution from 2016-2021 was performed. Patients with less than 2 years of follow-up after resection were excluded. Sarculator, a validated nomogram for soft-tissue sarcoma, was used to stratify patients into high- (< 60%) and low-risk (≥ 60%) prognostic groups based on their predicted overall survival (OS) at 10 years.
resultsThe cohort of 296 patients included 112 high- and 184 low-risk. 5-year OS was 70.5% in the high-risk group versus 90.9% in the low-risk group (P < 0.001). Most patients did not recur during the study period (n = 206). 26 patients recurred within 6 months from their initial surgery (18 high-risk, 8 low-risk) and all were offered immediate treatment after recurrence diagnosis. Of this cohort, 84.6% were offered immediate treatment after diagnosis of recurrence.
conclusionSurveillance strategies after primary resection should be tailored to patient's individual risk. Patients with low-risk clinicopathologic features have a lower chance of recurrence in the first two years and frequent surveillance visits may not impact their oncologic outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.